Amikacin?

Amikacin is an aminoglycoside antibiotic used to treat serious bacterial infections, including those affecting the lungs, urinary tract, skin, bones, and abdomen [1]. It is particularly effective against Gram-negative bacteria [1].

How does amikacin work?

Amikacin works by binding to the 30S ribosomal subunit of bacteria. This binding interferes with protein synthesis, leading to the production of abnormal bacterial proteins and ultimately cell death [1].

What are the different forms of amikacin?

Amikacin is available as an injectable solution for intravenous or intramuscular administration [1]. It is marketed under brand names such as Amikin [1].

When might amikacin be prescribed?

Doctors may prescribe amikacin for infections caused by susceptible bacteria, such as those found in complicated urinary tract infections, lower respiratory tract infections, skin and skin-structure infections, intra-abdominal infections, and bone and joint infections [1]. It is often used when other, less toxic antibiotics are not effective or are contraindicated [1].

What are the risks and side effects of amikacin?

Like other aminoglycosides, amikacin carries risks of nephrotoxicity (kidney damage) and ototoxicity (hearing or balance problems) [1]. These risks can be dose-dependent and may be increased in patients with pre-existing kidney impairment or those taking other ototoxic or nephrotoxic drugs [1]. Other potential side effects include neurotoxicity, gastrointestinal upset, and allergic reactions [1].

How long does amikacin treatment typically last?

The duration of amikacin treatment varies depending on the type and severity of the infection, but it is typically administered for 3 to 10 days [1].

What are the patent and exclusivity details for amikacin?

Amikacin is an older antibiotic with established generic availability. Information regarding its specific patent and exclusivity expirations can be found on DrugPatentWatch.com [2]. The landscape for older drugs like amikacin often involves generic competition rather than ongoing patent exclusivity disputes [2].

Who manufactures amikacin?

Several pharmaceutical companies manufacture amikacin, including generic versions. Specific manufacturers can be identified through drug databases and regulatory filings [1].

How does amikacin compare to other antibiotics?

Amikacin belongs to the aminoglycoside class, which includes drugs like gentamicin and tobramycin. While they share a similar mechanism of action and spectrum of activity against Gram-negative bacteria, there can be differences in their efficacy against specific pathogens, dosing regimens, and toxicity profiles [1]. Amikacin is often considered when resistance to other aminoglycosides is a concern [1].